PlumX Metrics
Embed PlumX Metrics

Increased CD34 in pancreatic islet negatively predict islet β-cell decrease in type1 diabetes model

Frontiers in Physiology, ISSN: 1664-042X, Vol: 13, Page: 1032774
2022
  • 2
    Citations
  • 0
    Usage
  • 5
    Captures
  • 2
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

Reports from Wannan Medical College Highlight Recent Findings in Proinsulin (Increased Cd34 In Pancreatic Islet Negatively Predict Islet Beta-cell Decrease In Type1 Diabetes Model)

2023 JAN 03 (NewsRx) -- By a News Reporter-Staff News Editor at Gastroenterology Daily News -- Investigators publish new report on Peptide Proteins - Proinsulin.

Article Description

Islet β-cell biomarkers can reflect changes in the number and function of islet β-cells in the prediabetes or early diabetes stage. CD34 is a commonly used stem cell biomarker; however, its expression and function in pancreatic islets remain unclear. In the present study, double immunofluorescence staining, proteomic bioinformatics analysis, and correlation analysis were used to explore the potential of CD34 as an islet β-cell biomarker. Bioinformatics analysis revealed that the amino acid sequence of CD34 was conserved among multiple species and abundantly expressed on mouse and human pancreatic tissues. Immunofluorescence demonstrated that in the control rat pancreas, CD34 was expressed on glucagon-labeled islet α-cells but not on insulin-labeled islet β-cells. Furthermore, the proportion of CD34-positive cells, which were also positive for glucagon, was significantly increased in alloxan-induced diabetes models. Statistical analysis revealed that the expression of CD34 was negatively correlated with the number of insulin-labeled islet β-cells during diabetes progression in dose-dependent fashion in alloxan-induced diabetes models. Furthermore, the results suggested that the transdifferentiation of islet β-cells into islet α-cells may occur in the process of diabetes. Thus, the present study demonstrated that CD34 is expressed on islet α-cells, and its number is linearly and negatively correlated with the number of islet β-cells, suggesting that CD34 can be used as a prospective biomarker for islet β-cells in the early diagnosis of diabetes. The study also suggests the transformation of β-cells to α-cells in diabetes which provide a potential to be applied towards diabetes mechanism research.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know